Related Experiment Videos
Micronuclei assay--a predictive variable for tumor response to treatment.
H Shidnia1, W Crabtree, N Hornback
1Indiana University School of Medicine, Indianapolis.
Advances in Experimental Medicine and Biology
|January 1, 1990
Summary
Micronuclei formation in tumor cells predicts treatment success. Higher micronuclei levels correlate with decreased tumor volume after radiation and hyperthermia therapy.
Area of Science:
- Oncology
- Radiation Oncology
- Cell Biology
Background:
- Assessing tumor response to radiation and hyperthermia is crucial for effective cancer treatment.
- Predictive biomarkers can optimize therapeutic strategies and improve patient outcomes.
Observation:
- A pilot study analyzed fine needle aspirate (FNA) samples from four patients undergoing radiation and hyperthermia.
- Micronuclei (MN) formation in tumor cells was measured before and during treatment (up to 3000 cGy).
Findings:
- Increased micronuclei formation strongly correlated with decreased tumor volume.
- All patients achieved tumor control for at least one year, suggesting a favorable response.
Implications:
- Micronuclei levels serve as a predictive biomarker for tumor response to radiation and hyperthermia.
- This simple FNA-based assay can be performed in clinics, offering a minimally invasive method for predicting treatment efficacy.